THE RNA PRINTER
LIVE

Serial Number

88347483

Owner

CUREVAC RNA PRINTER GMBH

Attorney

Jennifer Fraser

Filing Date

Mar 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

THE RNA PRINTER Trademark

Serial Number: 88347483 • Registration: 6285035

THE RNA PRINTER is a trademark filed by CUREVAC RNA PRINTER GMBH on March 19, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CUREVAC RNA PRINTER GMBH (4 trademarks)

FRIEDRICH-MIESCHER-STRASSE 15
TUBINGEN 72076 , DE

Entity Type: 27

CureVac AG

Tübingen 72076 , DE

Entity Type: 99

CUREVAC MANUFACTURING GMBH

FRIEDRICH-MIESCHER-STRASSE 15
TUBINGEN 72076 , DE

Entity Type: 27

Trademark Details

Filing Date

March 19, 2019

Registration Date

March 2, 2021

Goods & Services

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements

Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders

Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes

Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 2, 2026 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 4, 2025 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 25, 2022 ASGN
REGISTERED-SUPPLEMENTAL REGISTER
Mar 2, 2021 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 28, 2021 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 23, 2021 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 29, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 29, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 10, 2020 GNFN
FINAL REFUSAL E-MAILED
Jul 10, 2020 GNFR
FINAL REFUSAL WRITTEN
Jul 10, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 5, 2019 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 4, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 4, 2019 GNSL
SUSPENSION LETTER WRITTEN
Nov 4, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2019 CRFA
ASSIGNED TO LIE
Oct 10, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2019 CNRT
ASSIGNED TO EXAMINER
May 29, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2019 NWOS
NEW APPLICATION ENTERED
Mar 22, 2019 NWAP